Acute Gvhd: Biomarkers And Biology

Acute GVHD: Biomarkers and Biology

James Ferrara | ASH 2018 | How biology drives acute GvHD biomarkers

Mapping the future of Hemopoietic Cell Transplants: MAGIC Biomarkers

Icahn School of Medicine

Biomarker testing may transform treatment of acute GVHD (Part 1)

MDedge: news and insights for busy physicians

REG3α as a biomarker and therapeutic target for GVHD

Journal of Clinical Investigation

Targets, Mechanism, and Disease: Biomarker Development

Precision BMT Through Biomarkers

Icahn School of Medicine

Key biomarkers in the management of acute GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

What is a biomarker?

All of Us Research Program

Amphiregulin as a monitoring biomarker during treatment of acute GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Biomarker testing may transform treatment of acute GVHD (Part 2)

MDedge: news and insights for busy physicians

Overcoming the Challenges of Acute and Chronic GVHD

PeerView Oncology

Sequential ELISA For Validation Of Biomarkers Of Acute Graft-Versus-Host Disease l Protocol Preview

JoVE (Journal of Visualized Experiments)

What is the latest update on biomarkers for assessing GvHD?

Biomarkers for Graft-Versus-Host Disease: What Is a Biomarker?

Managed Healthcare Executive

GvHD biomarker discovery and validation

VJHemOnc – Video Journal of Hematology & HemOnc

Transforming GVHD Treatment: The Mount Sinai Acute GVHD International Consortium (MAGIC)

Icahn School of Medicine

Understanding Biomarkers

Biomarkers for GvHD risk in allo-SCT

VJHemOnc – Video Journal of Hematology & HemOnc

GvHD biology: tissue tolerance, the micriobiome & biomarkers

VJHemOnc – Video Journal of Hematology & HemOnc